Viewing StudyNCT00250926



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00250926
Status: COMPLETED
Last Update Posted: 2016-04-08
First Post: 2005-11-08

Brief Title: Study of the Combination of Bortezomib Dexamethasone and Rituximab in Patients With Waldenstroms Macroglobulinemia
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Organization Data

Organization: Dana-Farber Cancer Institute
Class: OTHER
Study ID: 05-180
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Dana-Farber Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: Steven P Treon MD PhD
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Dana-Farber Cancer Institute
Old Name: None
Old Organization: None

Collaborators

Name Class
Millennium Pharmaceuticals Inc INDUSTRY
Beth Israel Deaconess Medical Center OTHER